News
10x Genomics (TXG) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is ...
What a brutal six months it’s been for 10x Genomics. The stock has dropped 52.1% and now trades at $10.59, rattling many shareholders. This was partly due to its softer quarterly results and ...
Willowbrook, IL – In a blockbuster move, the nation’s top golf club fitter and builder, Club Champion, has acquired top Canadian fitter and builder Tour Experience Golf (TXG).
Below is Validea's guru fundamental report for 10X GENOMICS INC (TXG). Of the 22 guru strategies we follow, TXG rates highest using our P/B Growth Investor model based on the published strategy of ...
10x Genomics TXG shares soared 8.2% in the last trading session to close at $16.99. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares ...
Below is Validea's guru fundamental report for 10X GENOMICS INC (TXG). Of the 22 guru strategies we follow, TXG rates highest using our P/B Growth Investor model based on the published strategy of ...
Hosted on MSN14d
Life Sciences Tools & Services Stocks Q1 Results: Benchmarking 10x Genomics (NASDAQ:TXG)The 21 life sciences tools & services stocks we track reported a strong Q1. As a group, revenues beat analysts’ consensus estimates by 3.3% while next quarter’s revenue guidance was 0.5% above.
Toronto’s TXG Tour Experience Golf has been bought by Chicago’s Club Champion in a deal that tees up a new landscape in the niche but fast-growing custom golf club fitting sector in North America.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results